Several lncRNAs which have the potential to be used for therapeutics and can be delivered by exosomes to target sites include LOC285194 which suppressed tumor growth in NSCLC by regulating p53 [81] and FOXF1 Adjacent Noncoding Developmental Regulatory RNA (FENDRR) which too suppressed tumor growth, invasion and migration properties of NSCLC [82]. This evidence concerns the gene FOXF1 and non-small cell lung carcinoma.